BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lynch HT, Kaurah P, Wirtzfeld D, Rubinstein WS, Weissman S, Lynch JF, Grady W, Wiyrick S, Senz J, Huntsman DG. Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy. Cancer. 2008;112:2655-2663. [PMID: 18442100 DOI: 10.1002/cncr.23501] [Cited by in Crossref: 61] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Knipper K, Fuchs HF, Alakus H, Bruns CJ, Schmidt T. [Hereditary diffuse gastric cancer]. Chirurgie (Heidelb) 2023. [PMID: 36700973 DOI: 10.1007/s00104-023-01806-z] [Reference Citation Analysis]
2 Corso G, Tagliaferri V, Massari G, Cioffi A, Rossi EMC, Veronesi P, Magnoni F. CDH1 mutations recurrence and global clustering in genetically tested families with hereditary diffuse gastric cancer syndrome: results from a systematic study. Fam Cancer 2022. [PMID: 35882702 DOI: 10.1007/s10689-022-00309-w] [Reference Citation Analysis]
3 Gamble LA, Grant RRC, Samaranayake SG, Fasaye GA, Koh C, Korman L, Asif B, Heller T, Hernandez JM, Blakely AM, Davis JL. Decision-making and regret in patients with germline CDH1 variants undergoing prophylactic total gastrectomy. J Med Genet 2022:jmedgenet-2022-108733. [PMID: 35817563 DOI: 10.1136/jmg-2022-108733] [Reference Citation Analysis]
4 Corso G, Magnoni F, Nicastro V, Bagnardi V, Trovato CM, Veronesi P. Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations. Seminars in Oncology 2022. [DOI: 10.1053/j.seminoncol.2022.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Taja-Chayeb L, Vidal-Millán S, Trejo-Becerril C, Pérez-Cárdenas E, Chávez-Blanco A, Domínguez-Gómez G, González-Fierro A, Romo-Pérez A, Dueñas-González A. Hereditary Diffuse Gastric Cancer (HDGC). An overview. Clin Res Hepatol Gastroenterol 2021;:101820. [PMID: 34656755 DOI: 10.1016/j.clinre.2021.101820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Ruiz de la Cruz M, de la Cruz Montoya AH, Rojas Jiménez EA, Martínez Gregorio H, Díaz Velásquez CE, Paredes de la Vega J, de la Cruz Hernández-Hernández F, Vaca Paniagua F. Cis-Acting Factors Causing Secondary Epimutations: Impact on the Risk for Cancer and Other Diseases. Cancers (Basel) 2021;13:4807. [PMID: 34638292 DOI: 10.3390/cancers13194807] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Hoskins C, Tutty E, Purvis R, Shanahan M, Boussioutas A, Forrest L. Young people's experiences of a CDH1 pathogenic variant: Decision-making about gastric cancer risk management. J Genet Couns 2021. [PMID: 34265132 DOI: 10.1002/jgc4.1478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ithurralde-Argerich J, Rosner L, Rizzolo M, Faerberg A, Puma R, Ferro D, Duque C, Kujaruk M, Cuenca-Abente F. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in CDH1 Mutation Carriers. J Laparoendosc Adv Surg Tech A 2021;31:729-37. [PMID: 34097461 DOI: 10.1089/lap.2021.0239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Massari G, Magnoni F, Favia G, Peradze N, Veronesi P, La Vecchia C, Corso G. Frequency of CDH1 Germline Mutations in Non-Gastric Cancers. Cancers (Basel) 2021;13:2321. [PMID: 34066044 DOI: 10.3390/cancers13102321] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Corso G, Corso F, Bellerba F, Carneiro P, Seixas S, Cioffi A, La Vecchia C, Magnoni F, Bonanni B, Veronesi P, Gandini S, Figueiredo J. Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review. Cancers (Basel) 2021;13:1269. [PMID: 33809393 DOI: 10.3390/cancers13061269] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
11 Vos EL, Salo-Mullen EE, Tang LH, Schattner M, Yoon SS, Gerdes H, Markowitz AJ, Mandelker D, Janjigian Y, Offitt K, Coit DG, Stadler ZK, Strong VE. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies. JAMA Surg 2020;155:1050-7. [PMID: 32997132 DOI: 10.1001/jamasurg.2020.3356] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
12 Shenoy S. CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management. Cancer Manag Res 2019;11:10477-86. [PMID: 31853199 DOI: 10.2147/CMAR.S208818] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
13 Lynch HT, Nustas R, Kassim T, Snyder C, Shaw T, Diab O. The benefits of a model of interval comprehensive assessments (MICA) in hereditary cancer Syndromes: Hereditary diffuse gastric cancer (HDGC) as an example. Cancer Genetics 2019;233-234:43-7. [DOI: 10.1016/j.cancergen.2019.03.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 De Scalzi AM, Bonanni B, Galimberti V, Veronesi P, Pravettoni G, Corso G. E-cadherin germline mutations in Māori population. Future Oncology 2019;15:1291-4. [DOI: 10.2217/fon-2018-0834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Figueiredo J, Melo S, Carneiro P, Moreira AM, Fernandes MS, Ribeiro AS, Guilford P, Paredes J, Seruca R. Clinical spectrum and pleiotropic nature of CDH1 germline mutations. J Med Genet. 2019;56:199-208. [PMID: 30661051 DOI: 10.1136/jmedgenet-2018-105807] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 12.0] [Reference Citation Analysis]
16 Rocha JP, Gullo I, Wen X, Devezas V, Baptista M, Oliveira C, Carneiro F. Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management. Histopathology 2018;73:878-86. [PMID: 30014492 DOI: 10.1111/his.13715] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
17 Matsuoka T, Yashiro M. Biomarkers of gastric cancer: Current topics and future perspective. World J Gastroenterol 2018; 24(26): 2818-2832 [PMID: 30018477 DOI: 10.3748/wjg.v24.i26.2818] [Cited by in CrossRef: 188] [Cited by in F6Publishing: 201] [Article Influence: 37.6] [Reference Citation Analysis]
18 Zylberberg HM, Sultan K, Rubin S. Hereditary diffuse gastric cancer: One family’s story. World J Clin Cases 2018; 6(1): 1-5 [PMID: 29376063 DOI: 10.12998/wjcc.v6.i1.1] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
19 Strong VE, Gholami S, Shah MA, Tang LH, Janjigian YY, Schattner M, Selby LV, Yoon SS, Salo-Mullen E, Stadler ZK, Kelsen D, Brennan MF, Coit DG. Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients. Ann Surg 2017;266:1006-12. [PMID: 27759617 DOI: 10.1097/SLA.0000000000002030] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 6.2] [Reference Citation Analysis]
20 Hallowell N, Badger S, Richardson S, Caldas C, Hardwick RH, Fitzgerald RC, Lawton J. An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC). Fam Cancer. 2016;15:665-676. [PMID: 27256430 DOI: 10.1007/s10689-016-9910-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
21 Muir J, Aronson M, Esplen MJ, Pollett A, Swallow CJ. Prophylactic Total Gastrectomy: a Prospective Cohort Study of Long-Term Impact on Quality of Life. J Gastrointest Surg 2016;20:1950-8. [PMID: 27752808 DOI: 10.1007/s11605-016-3287-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
22 Graffeo R, Livraghi L, Pagani O, Goldhirsch A, Partridge AH, Garber JE. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care. Breast Cancer Res Treat 2016;160:393-410. [DOI: 10.1007/s10549-016-4003-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
23 Hüneburg R, Marwitz T, van Heteren P, Weismüller TJ, Trebicka J, Adam R, Aretz S, Perez Bouza A, Pantelis D, Kalff JC, Nattermann J, Strassburg CP. Chromoendoscopy in combination with random biopsies does not improve detection of gastric cancer foci in CDH1 mutation positive patients. Endosc Int Open 2016;4:E1305-10. [PMID: 27995193 DOI: 10.1055/s-0042-112582] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
24 Rogers M. Cate’s Story: Hereditary Diffuse Gastric Cancer. CJON 2016;20:443-445. [DOI: 10.1188/16.cjon.443-445] [Reference Citation Analysis]
25 van der Post RS, Vogelaar IP, Manders P, van der Kolk LE, Cats A, van Hest LP, Sijmons R, Aalfs CM, Ausems MG, Gómez García EB, Wagner A, Hes FJ, Arts N, Mensenkamp AR, van Krieken JH, Hoogerbrugge N, Ligtenberg MJ. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1. Gastroenterology 2015;149:897-906.e19. [PMID: 26072394 DOI: 10.1053/j.gastro.2015.06.003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 7.1] [Reference Citation Analysis]
26 Lianos GD, Bali CD, Katsios C, Roukos DH. From traditional to whole-genome sequencing biomarkers for gastric cancer. Biomark Med 2015;9:559-62. [PMID: 26079960 DOI: 10.2217/bmm.15.19] [Reference Citation Analysis]
27 Pinheiro H, Oliveira C, Seruca R, Carneiro F. Hereditary diffuse gastric cancer - pathophysiology and clinical management. Best Pract Res Clin Gastroenterol 2014;28:1055-68. [PMID: 25439071 DOI: 10.1016/j.bpg.2014.09.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
28 Corso G, Figueiredo J, Biffi R, Trentin C, Bonanni B, Feroce I, Serrano D, Cassano E, Annibale B, Melo S, Seruca R, De Lorenzi F, Ferrara F, Piagnerelli R, Roviello F, Galimberti V. E-cadherin germline mutation carriers: clinical management and genetic implications. Cancer Metastasis Rev 2014;33:1081-94. [DOI: 10.1007/s10555-014-9528-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
29 Evans DG, Ingham SL. Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors. Appl Clin Genet 2013;6:53-61. [PMID: 23935382 DOI: 10.2147/TACG.S35605] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
30 Majewski IJ, Kluijt I, Cats A, Scerri TS, de Jong D, Kluin RJ, Hansford S, Hogervorst FB, Bosma AJ, Hofland I. An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer. J Pathol. 2013;229:621-629. [PMID: 23208944 DOI: 10.1002/path.4152] [Cited by in Crossref: 138] [Cited by in F6Publishing: 145] [Article Influence: 13.8] [Reference Citation Analysis]
31 Gru AA, Allred DC. Molecular Pathology of Breast Cancer. Molecular Surgical Pathology 2013. [DOI: 10.1007/978-1-4614-4900-3_6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
32 Carneiro F, Oliveira C, Seruca R. Hereditary Diffuse Gastric Cancer and Other Gastric Cancers Associated with Hereditary Predisposition Syndromes. Molecular Pathology Library 2013. [DOI: 10.1007/978-1-4614-6015-2_6] [Reference Citation Analysis]
33 Carneiro F. Pathology of Hereditary Gastric Cancer. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Thiagarajan P, Jankowski JA. Why is there a change in patterns of GE cancer? Recent Results Cancer Res 2012;196:115-40. [PMID: 23129370 DOI: 10.1007/978-3-642-31629-6_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
35 Fukuchi M, Sakurai S, Tsukagoshi R, Suzuki M, Yamauchi H, Tabe Y, Fukasawa T, Kiriyama S, Naitoh H, Kuwano H. Eleven metachronous early gastric cancers in an elderly woman. Clin J Gastroenterol 2012;5:367-71. [PMID: 26181077 DOI: 10.1007/s12328-012-0331-4] [Reference Citation Analysis]
36 Onitilo AA, Aryal G, Engel JM. Hereditary diffuse gastric cancer: a family diagnosis and treatment. Clin Med Res. 2013;11:36-41. [PMID: 22723466 DOI: 10.3121/cmr.2012.1071] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
37 Seevaratnam R, Coburn N, Cardoso R, Dixon M, Bocicariu A, Helyer L. A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer. Gastric Cancer. 2012;15 Suppl 1:S153-S163. [PMID: 22160243 DOI: 10.1007/s10120-011-0116-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
38 Baltogiannis G, Katsios CS, Roukos DH. Targeting the individual cancer patient. Advances in personalized cancer management. Unitec House: Future Medicine Ltd; 2011. pp. 8-28. [DOI: 10.2217/ebo.11.279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Mastoraki A, Danias N, Arkadopoulos N, Sakorafas G, Vasiliou P, Smyrniotis V. Prophylactic total gastrectomy for hereditary diffuse gastric cancer. Review of the literature. Surg Oncol. 2011;20:e223-e226. [PMID: 21872467 DOI: 10.1016/j.suronc.2011.08.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
40 Lynch HT, Aldoss I, Lynch JF. The identification and management of hereditary diffuse gastric cancer in a large Jordanian family. Familial Cancer 2011;10:667-72. [DOI: 10.1007/s10689-011-9463-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
41 Bornschein J, Malfertheiner P. Gastric carcinogenesis. Langenbecks Arch Surg. 2011;396:729-742. [PMID: 21611816 DOI: 10.1007/s00423-011-0810-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
42 Yu J, Li Z. The sex ratio and age of onset features of gastric cancer patients in hereditary diffuse gastric cancer families. Familial Cancer 2011;10:573-9. [DOI: 10.1007/s10689-011-9452-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
43 Fukamachi H, Shimada S, Ito K, Ito Y, Yuasa Y. CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation. Cancer Sci. 2011;102:1313-1321. [PMID: 21457403 DOI: 10.1111/j.1349-7006.2011.01947.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
44 Rebai W, Makni A, Ksantini R, Chebbi F, Baraket O, Fteriche F, Ayadi S, Daghfous A, Bedioui H, Jouini M, Kacem M, Ben Safta Z. Adénocarcinome gastrique du jeune tunisien: à propos de 18 cas. J Afr Cancer 2011;3:114-119. [DOI: 10.1007/s12558-011-0145-1] [Reference Citation Analysis]
45 Piazuelo MB, Epplein M, Correa P. Gastric cancer: an infectious disease. Infect Dis Clin North Am 2010;24:853-69, vii. [PMID: 20937454 DOI: 10.1016/j.idc.2010.07.010] [Cited by in Crossref: 60] [Cited by in F6Publishing: 67] [Article Influence: 5.0] [Reference Citation Analysis]
46 Xie ZM, Li LS, Laquet C, Penault-Llorca F, Uhrhammer N, Xie XM, Bignon YJ. Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer. Cancer. 2011;117:3112-3117. [PMID: 21271559 DOI: 10.1002/cncr.25876] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
47 Slater EP, Langer P, Fendrich V, Habbe N, Chaloupka B, Matthäi E, Sina M, Hahn SA, Bartsch DK. Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families. Fam Cancer. 2010;9:335-343. [PMID: 20195775 DOI: 10.1007/s10689-010-9329-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
48 Becker K, Keller G. Gastric Cancer. eLS 2010. [DOI: 10.1002/9780470015902.a0006056.pub2] [Reference Citation Analysis]
49 Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V, Chung DC, Norton J, Ragunath K, Van Krieken JH, Dwerryhouse S, Caldas C;  International Gastric Cancer Linkage Consortium. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010;47:436-444. [PMID: 20591882 DOI: 10.1136/jmg.2009.074237] [Cited by in Crossref: 380] [Cited by in F6Publishing: 411] [Article Influence: 29.2] [Reference Citation Analysis]
50 Wolf E, Geigl J, Svrcek M, Vieth M, Langner C. Hereditäres Magenkarzinom. Pathologe 2010;31:423-9. [DOI: 10.1007/s00292-010-1353-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
51 Lee AF, Rees H, Owen DA, Huntsman DG. Periodic acid-schiff is superior to hematoxylin and eosin for screening prophylactic gastrectomies from CDH1 mutation carriers. Am J Surg Pathol 2010;34:1007-13. [PMID: 20534996 DOI: 10.1097/PAS.0b013e3181e28985] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
52 Ghaffari S, Rafati M, Sabokbar T, Dastan J. A novel truncating mutation in the E-cadherin gene in the first Iranian family with hereditary diffuse gastric cancer. European Journal of Surgical Oncology (EJSO) 2010;36:559-62. [DOI: 10.1016/j.ejso.2010.04.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
53 Mayrbaeurl B, Keller G, Schauer W, Burgstaller S, Czompo M, Hoebling W, Knoflach P, Duba HC, Hoefler H, Thaler J. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members. Eur J Gastroenterol Hepatol 2010;22:306-10. [PMID: 19474748 DOI: 10.1097/MEG.0b013e32832bab9a] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
54 A. Abrams J, Wang TC. Adenocarcinoma and Other Tumors of the Stomach. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 2010. [DOI: 10.1016/b978-1-4160-6189-2.00054-8] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
55 Schrader K, Huntsman D. Hereditary diffuse gastric cancer. Cancer Treat Res 2010;155:33-63. [PMID: 20517687 DOI: 10.1007/978-1-4419-6033-7_3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
56 Milne AN, Carneiro F, O'Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009;126:615-628. [PMID: 19657673 DOI: 10.1007/x00439-009-0722-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Milne AN, Carneiro F, O'Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009;126:615-628. [PMID: 19657673 DOI: 10.1007/s00439-009-0722-x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 145] [Article Influence: 11.1] [Reference Citation Analysis]
58 Ziogas D, Roukos DH. CDH1 testing: can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer? Ann Surg Oncol 2009;16:2678-81. [PMID: 19636637 DOI: 10.1245/s10434-009-0598-y] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 5.2] [Reference Citation Analysis]
59 Bornschein J, Weigt J, Selgrad M, Malfertheiner P. Molecular aspects in the diagnosis of gastric cancer. Expert Opin Med Diagn 2009;3:585-96. [PMID: 23495987 DOI: 10.1517/17530050902862175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
60 Oliveira C, Sousa S, Pinheiro H, Karam R, Bordeira-Carriço R, Senz J, Kaurah P, Carvalho J, Pereira R, Gusmão L, Wen X, Cipriano MA, Yokota J, Carneiro F, Huntsman D, Seruca R. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 2009;136:2137-48. [PMID: 19269290 DOI: 10.1053/j.gastro.2009.02.065] [Cited by in Crossref: 120] [Cited by in F6Publishing: 128] [Article Influence: 8.6] [Reference Citation Analysis]
61 Hebbard PC, Macmillan A, Huntsman D, Kaurah P, Carneiro F, Wen X, Kwan A, Boone D, Bursey F, Green J. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients. Ann Surg Oncol. 2009;16:1890-1895. [PMID: 19408054 DOI: 10.1245/s10434-009-0471-z] [Cited by in Crossref: 78] [Cited by in F6Publishing: 86] [Article Influence: 5.6] [Reference Citation Analysis]
62 Tokunaga M, Ohyama S, Kuraoka K, Hiki N, Fukunaga T, Tsuchida T, Fujisaki J, Yamamoto N, Yamaguchi T. Twenty-two metachronous multiple signet-ring cell carcinomas treated with repeated gastrectomies and repeated endoscopic mucosal resections: report of a case. Surg Today 2009;39:430-3. [PMID: 19408083 DOI: 10.1007/s00595-008-3862-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
63 Oliveira C, Seruca R, Carneiro F. Hereditary gastric cancer. Best Pract Res Clin Gastroenterol 2009;23:147-57. [PMID: 19414142 DOI: 10.1016/j.bpg.2009.02.003] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.6] [Reference Citation Analysis]
64 Xu WQ, Song LJ, Liu Q, Zhao L, Zheng L, Yan ZW, Fu GH. Expression of anion exchanger 1 is associated with tumor progress in human gastric cancer. J Cancer Res Clin Oncol. 2009;135:1323-1330. [PMID: 19330352 DOI: 10.1007/s00432-009-0573-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
65 Oliveira C, Senz J, Kaurah P, Pinheiro H, Sanges R, Haegert A, Corso G, Schouten J, Fitzgerald R, Vogelsang H. Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet. 2009;18:1545-1555. [PMID: 19168852 DOI: 10.1093/hmg/ddp046] [Cited by in Crossref: 146] [Cited by in F6Publishing: 157] [Article Influence: 10.4] [Reference Citation Analysis]
66 Lynch HT, Marcus JN, Lynch J, Snyder CL, Rubinstein WS. Breast Cancer Genetics. The Breast. Elsevier; 2009. pp. 371-415. [DOI: 10.1016/b978-1-4160-5221-0.00021-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
67 Carneiro F, Oliveira C, Leite M, Seruca R. Molecular targets and biological modifiers in gastric cancer. Semin Diagn Pathol. 2008;25:274-287. [PMID: 19013893 DOI: 10.1053/j.semdp.2008.07.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
68 Lynch HT, Silva E, Wirtzfeld D, Hebbard P, Lynch J, Huntsman DG. Hereditary diffuse gastric cancer: prophylactic surgical oncology implications. Surg Clin North Am 2008;88:759-78, vi-vii. [PMID: 18672140 DOI: 10.1016/j.suc.2008.04.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]